Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

NCT00497952 is registered in ClinicalTrials.gov with Talaris Therapeutics Inc. as lead sponsor.

NCT NCT00497952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00497952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Lead sponsor
Talaris Therapeutics Inc.
Phase
Phase 1/2
Overall status
Withdrawn
Start date
July 31, 2007
Completion date
December 31, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis